SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 149 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.3%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,107,283 | -16.4% | 566,924 | -5.2% | 0.00% | -50.0% |
| Q2 2023 | $15,679,717 | +49.6% | 598,006 | +46.9% | 0.00% | +100.0% |
| Q1 2023 | $10,479,000 | +89448.8% | 407,108 | -9.5% | 0.00% | -50.0% |
| Q4 2022 | $11,702 | -99.9% | 449,927 | +16.5% | 0.00% | 0.0% |
| Q3 2022 | $11,022,000 | -15.0% | 386,342 | -26.7% | 0.00% | 0.0% |
| Q2 2022 | $12,971,000 | +171.5% | 526,829 | +522.3% | 0.00% | +100.0% |
| Q1 2022 | $4,778,000 | +244.5% | 84,665 | +278.5% | 0.00% | – |
| Q4 2021 | $1,387,000 | +7.3% | 22,367 | +9.7% | 0.00% | – |
| Q3 2021 | $1,293,000 | -21.1% | 20,384 | +2.6% | 0.00% | – |
| Q2 2021 | $1,638,000 | +46.8% | 19,866 | +31.0% | 0.00% | – |
| Q1 2021 | $1,116,000 | +41.6% | 15,163 | +39.7% | 0.00% | – |
| Q4 2020 | $788,000 | +114.1% | 10,854 | +37.4% | 0.00% | – |
| Q3 2020 | $368,000 | -47.0% | 7,899 | -52.2% | 0.00% | – |
| Q2 2020 | $694,000 | +646.2% | 16,514 | +380.3% | 0.00% | – |
| Q1 2020 | $93,000 | -29.0% | 3,438 | +1.0% | 0.00% | – |
| Q4 2019 | $131,000 | – | 3,404 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 3,081,307 | $79,313 | 9.91% |
| Finepoint Capital LP | 614,231 | $15,810,306 | 6.04% |
| M28 Capital Management LP | 197,700 | $5,088,798 | 5.75% |
| Boxer Capital, LLC | 3,421,541 | $88,070 | 4.33% |
| Deep Track Capital, LP | 3,100,000 | $79,794,000 | 3.28% |
| EcoR1 Capital, LLC | 3,460,208 | $89,065,754 | 2.87% |
| Artal Group S.A. | 1,817,349 | $46,779 | 2.78% |
| Orbimed Advisors | 4,498,900 | $115,801,686 | 2.27% |
| Perceptive Advisors | 2,079,352 | $53,522,520 | 1.58% |
| SPHERA FUNDS MANAGEMENT LTD. | 317,625 | $8,175,668 | 1.37% |